Multidrug-resistant sepsis in special newborn care units in five district hospitals in India: a prospective cohort study.

IF 19.9 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
Lancet Global Health Pub Date : 2025-05-01 Epub Date: 2025-02-26 DOI:10.1016/S2214-109X(24)00564-3
Kajal Jain, Vivek Kumar, Nishad Plakkal, Deepak Chawla, Atul Jindal, Reeta Bora, Neeraj Gupta, Apurba Sastry, Nidhi Singla, Anudita Bhargava, Reema Nath, Vijayalakshmi Nag, Sarita Mohapatra, Nitya Wadhwa, Ramesh Agarwal, M Jeeva Sankar
{"title":"Multidrug-resistant sepsis in special newborn care units in five district hospitals in India: a prospective cohort study.","authors":"Kajal Jain, Vivek Kumar, Nishad Plakkal, Deepak Chawla, Atul Jindal, Reeta Bora, Neeraj Gupta, Apurba Sastry, Nidhi Singla, Anudita Bhargava, Reema Nath, Vijayalakshmi Nag, Sarita Mohapatra, Nitya Wadhwa, Ramesh Agarwal, M Jeeva Sankar","doi":"10.1016/S2214-109X(24)00564-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Neonatal sepsis epidemiology has been adequately reported in tertiary-care hospitals. However, such data are scarce from district hospitals in low-income and middle-income countries. This study aimed to evaluate the incidence of sepsis, pathogen profile, and antimicrobial resistance among neonates admitted to the special newborn care units in district hospitals in India.</p><p><strong>Methods: </strong>We prospectively enrolled neonates admitted to newborn units in five district hospitals in India between October, 2019, and December, 2021. Blood cultures were obtained from neonates who met prespecified criteria and were processed at the laboratories of the tertiary-care hospitals linked to each district hospital. Identification of pathogens and antimicrobial susceptibility testing was performed using the automated system; all isolates were confirmed using matrix-assisted laser desorption-ionisation-time of flight. The primary outcome was the incidence of culture-positive sepsis. The final label of culture-positive sepsis was assigned based on culture reports and clinical course. Multidrug resistance was defined as resistance to antibiotics in at least three of the six antibiotic classes, including third generation cephalosporins, carbapenems, and aminoglycosides.</p><p><strong>Findings: </strong>The study enrolled 6612 neonates (3972 inborn [born at the same hospital] and 2640 outborn [referred from other hospitals or homes]). Mean gestation was 37·1 weeks and mean birthweight was 2540 g. 3357 (50·8%) neonates met clinical sepsis criteria. The overall incidence of culture-positive sepsis was 213 (3·2%; 95% CI 0·6-14·4); ranging from 0·6% to 10·0% across the five sites. The incidence was higher in outborn neonates than inborn neonates: 132 [5·0%] versus 81 [2·0%]. The case-fatality rate of culture-positive sepsis was 36·6% (95% CI 12·1-71·0). Gram-negative bacilli accounted for 156 (70·0%) of 223 organisms isolated: Klebsiella pneumoniae (51 [22·9%]), Escherichia coli (33 [14·8%]), and Enterobacter spp (26 [11·7%]) were the most common Gram-negative organisms. 75%-88% of isolates of K pneumoniae, E coli, Enterobacter spp, and Acinetobacter baumannii were multidrug resistant.</p><p><strong>Interpretation: </strong>The high incidence of culture-positive sepsis, case-fatality rates, and multidrug resistance among common pathogens underscores an urgent need to strengthen infection prevention and control practices, establish blood culture facilities, and implement antimicrobial stewardship programmes in district-level hospitals in India.</p><p><strong>Funding: </strong>Bill & Melinda Gates Foundation.</p><p><strong>Translation: </strong>For the Hindi translation of the abstract see Supplementary Materials section.</p>","PeriodicalId":48783,"journal":{"name":"Lancet Global Health","volume":" ","pages":"e870-e878"},"PeriodicalIF":19.9000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12021664/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Global Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/S2214-109X(24)00564-3","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/26 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Neonatal sepsis epidemiology has been adequately reported in tertiary-care hospitals. However, such data are scarce from district hospitals in low-income and middle-income countries. This study aimed to evaluate the incidence of sepsis, pathogen profile, and antimicrobial resistance among neonates admitted to the special newborn care units in district hospitals in India.

Methods: We prospectively enrolled neonates admitted to newborn units in five district hospitals in India between October, 2019, and December, 2021. Blood cultures were obtained from neonates who met prespecified criteria and were processed at the laboratories of the tertiary-care hospitals linked to each district hospital. Identification of pathogens and antimicrobial susceptibility testing was performed using the automated system; all isolates were confirmed using matrix-assisted laser desorption-ionisation-time of flight. The primary outcome was the incidence of culture-positive sepsis. The final label of culture-positive sepsis was assigned based on culture reports and clinical course. Multidrug resistance was defined as resistance to antibiotics in at least three of the six antibiotic classes, including third generation cephalosporins, carbapenems, and aminoglycosides.

Findings: The study enrolled 6612 neonates (3972 inborn [born at the same hospital] and 2640 outborn [referred from other hospitals or homes]). Mean gestation was 37·1 weeks and mean birthweight was 2540 g. 3357 (50·8%) neonates met clinical sepsis criteria. The overall incidence of culture-positive sepsis was 213 (3·2%; 95% CI 0·6-14·4); ranging from 0·6% to 10·0% across the five sites. The incidence was higher in outborn neonates than inborn neonates: 132 [5·0%] versus 81 [2·0%]. The case-fatality rate of culture-positive sepsis was 36·6% (95% CI 12·1-71·0). Gram-negative bacilli accounted for 156 (70·0%) of 223 organisms isolated: Klebsiella pneumoniae (51 [22·9%]), Escherichia coli (33 [14·8%]), and Enterobacter spp (26 [11·7%]) were the most common Gram-negative organisms. 75%-88% of isolates of K pneumoniae, E coli, Enterobacter spp, and Acinetobacter baumannii were multidrug resistant.

Interpretation: The high incidence of culture-positive sepsis, case-fatality rates, and multidrug resistance among common pathogens underscores an urgent need to strengthen infection prevention and control practices, establish blood culture facilities, and implement antimicrobial stewardship programmes in district-level hospitals in India.

Funding: Bill & Melinda Gates Foundation.

Translation: For the Hindi translation of the abstract see Supplementary Materials section.

印度五个地区医院新生儿特别护理病房中的耐多药败血症:一项前瞻性队列研究。
背景:新生儿脓毒症流行病学已充分报道在三级保健医院。然而,来自低收入和中等收入国家的地区医院的此类数据很少。本研究旨在评估印度地区医院特殊新生儿护理单位新生儿脓毒症、病原体概况和抗菌素耐药性的发生率。方法:前瞻性纳入2019年10月至2021年12月期间在印度五家地区医院新生儿病房住院的新生儿。从符合预先规定标准的新生儿身上获得血液培养,并在与每个区医院有联系的三级保健医院的实验室进行处理。采用自动化系统进行病原菌鉴定和药敏试验;所有分离物均采用基质辅助激光解吸-电离飞行时间法进行鉴定。主要结果是培养阳性脓毒症的发生率。培养阳性脓毒症的最终标签是根据培养报告和临床过程来确定的。多重耐药被定义为对六类抗生素中至少三种抗生素的耐药,包括第三代头孢菌素、碳青霉烯类和氨基糖苷类。研究结果:该研究纳入了6612名新生儿(3972名新生儿[在同一家医院出生]和2640名新生儿[从其他医院或家庭转诊])。平均妊娠37.1周,平均出生体重2540 g, 3357例(50.8%)新生儿符合临床脓毒症标准。培养阳性脓毒症的总发病率为213例(3.2%;95% ci 0.6 - 14.4);五个站点的范围从0.6%到10.0%。早产儿的发病率高于新生儿:132例[5.0%]比81例[2.0%]。培养阳性脓毒症的病死率为36.6% (95% CI 12.1 ~ 70.1)。223株分离出革兰氏阴性杆菌156株(70·0%),其中以肺炎克雷伯菌51株(22.9%)、大肠杆菌33株(14.8%)、肠杆菌26株(11.7%)最为常见。肺炎克氏菌、大肠杆菌、肠杆菌和鲍曼不动杆菌的多重耐药率为75% ~ 88%。解释:培养阳性脓毒症的高发病率、病死率和常见病原体的多药耐药性突出了印度迫切需要加强感染预防和控制措施,建立血液培养设施,并在区级医院实施抗菌药物管理规划。资助:比尔及梅琳达·盖茨基金会。翻译:关于摘要的印地语翻译,请参阅补充资料部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Lancet Global Health
Lancet Global Health PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
CiteScore
44.10
自引率
1.20%
发文量
763
审稿时长
10 weeks
期刊介绍: The Lancet Global Health is an online publication that releases monthly open access (subscription-free) issues.Each issue includes original research, commentary, and correspondence.In addition to this, the publication also provides regular blog posts. The main focus of The Lancet Global Health is on disadvantaged populations, which can include both entire economic regions and marginalized groups within prosperous nations.The publication prefers to cover topics related to reproductive, maternal, neonatal, child, and adolescent health; infectious diseases (including neglected tropical diseases); non-communicable diseases; mental health; the global health workforce; health systems; surgery; and health policy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信